Skip to content

The development and transformation project of electric anti-nausea instrument for pregnant women using nerve conduction technology based on low frequency electrical stimulation on skin

The development and transformation project of electric anti-nausea instrument for pregnant women using nerve conduction technology based on low frequency electrical stimulation on skin

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009817
Enrollment
Unknown
Registered
2016-11-10
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nausea from pregnant women

Interventions

Test group:Apply electric anti-nausea instrument for pregnant women for treatment
Control group:Apply non-functional device

Sponsors

Shanghai First Maternity and Infant Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The patient whose gestational age is about 6-12 weeks, clinical and ultrasound diagnosis of pregnancy, excluding hydatidiform mole, ectopic pregnancy, threatening abortion, etc. She has the symptoms of nausea and vomiting for at least 3 days; 2. The patient should be above 18, and available by phone; 3. The patient whose symptoms of nausea and vomiting are not caused by non-pregnancy; 4. The patient who agrees to sign informed consent according to .

Exclusion criteria

Exclusion criteria: 1. The patients who don't understand or cooperate with rules; 2. The patients who wear implanted or external medical devices such as a pacemaker, a blood glucose meter or artificial cochlea and so on; 3. The patients who cant express themselves, such as clinically apparent nervous system abnormalities, or nervous system degenerative abnormalities; 4. The symptoms of nausea and vomiting are not caused by pregnancy, including thyroid disease, liver disease, acquired immune deficiency syndrome, diabetes, gallbladder disease, peptic ulcer disease, malignant tumor chemotherapy, antibiotics, antidepressant drugs, alcohol or drug addicts; 5. Other patients who are considered unsuitable for observation by doctors.

Design outcomes

Primary

MeasureTime frame
Vomit;

Secondary

MeasureTime frame
Nausea;apositia;Blood K+;Medicine;U-Ket;

Countries

China

Contacts

Public ContactHeqing Lu

Shanghai First Maternity and Infant Hospital

luheqing0811@126.com+86 13371985141

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026